Anti-PPAN monoclonal antibody

Pre-made anti-PPAN monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PPAN/PPAN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1433-Ab-1/ GM-Tg-hg-IP1433-Ab-2Anti-Human PPAN monoclonal antibodyHuman
GM-Tg-rg-IP1433-Ab-1/ GM-Tg-rg-IP1433-Ab-2Anti-Rat PPAN monoclonal antibodyRat
GM-Tg-mg-IP1433-Ab-1/ GM-Tg-mg-IP1433-Ab-2Anti-Mouse PPAN monoclonal antibodyMouse
GM-Tg-cynog-IP1433-Ab-1/ GM-Tg-cynog-IP1433-Ab-2Anti-Cynomolgus/ Rhesus macaque PPAN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1433-Ab-1/ GM-Tg-felg-IP1433-Ab-2Anti-Feline PPAN monoclonal antibodyFeline
GM-Tg-cang-IP1433-Ab-1/ GM-Tg-cang-IP1433-Ab-2Anti-Canine PPAN monoclonal antibodyCanine
GM-Tg-bovg-IP1433-Ab-1/ GM-Tg-bovg-IP1433-Ab-2Anti-Bovine PPAN monoclonal antibodyBovine
GM-Tg-equg-IP1433-Ab-1/ GM-Tg-equg-IP1433-Ab-2Anti-Equine PPAN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1433-Ab-1/ GM-Tg-hg-IP1433-Ab-2; GM-Tg-rg-IP1433-Ab-1/ GM-Tg-rg-IP1433-Ab-2;
GM-Tg-mg-IP1433-Ab-1/ GM-Tg-mg-IP1433-Ab-2; GM-Tg-cynog-IP1433-Ab-1/ GM-Tg-cynog-IP1433-Ab-2;
GM-Tg-felg-IP1433-Ab-1/ GM-Tg-felg-IP1433-Ab-2; GM-Tg-cang-IP1433-Ab-1/ GM-Tg-cang-IP1433-Ab-2;
GM-Tg-bovg-IP1433-Ab-1/ GM-Tg-bovg-IP1433-Ab-2; GM-Tg-equg-IP1433-Ab-1/ GM-Tg-equg-IP1433-Ab-2
Products NameAnti-PPAN monoclonal antibody
Formatmab
Target NamePPAN
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PPAN monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1433-Ag-1Recombinant multi-species SSF1/ PPAN/ BXDC3 protein


    Target information

    Target IDGM-IP1433
    Target NamePPAN
    Gene ID56342,235036
    Gene Symbol and SynonymsA230087P06Rik,BXDC3,PPAN,SSF,SSF-1,SSF1,SSF2
    Uniprot AccessionQ9NQ55
    Uniprot Entry NameSSF1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130810
    Target ClassificationN/A

    The target: PPAN, gene name: PPAN, also named as BXDC3, SSF, SSF-1, SSF1, SSF2. The protein encoded by this gene is an evolutionarily conserved protein similar to yeast SSF1 as well as to the gene product of the Drosophila gene peter pan (ppan). SSF1 is known to be involved in the second step of mRNA splicing. Both SSF1 and ppan are essential for cell growth and proliferation. Exogenous expression of this gene was reported to reduce the anchorage-independent growth of some tumor cells. Read-through transcription of this gene with P2RY11/P2Y(11), an adjacent downstream gene that encodes an ATP receptor, has been found. These read-through transcripts are ubiquitously present and up-regulated during granulocyte differentiation. [provided by RefSeq, Nov 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.